Crocs, Inc. (CROX): who owns it and who trades it
As of Nov 16, 2026, CROX insiders reported 22 open-market sales worth $23M and 4 purchases worth $613K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Andrew Rees (CEO), with $14.1M. 9 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Crocs
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Funds and famous investors were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns CROX
497 funds and institutions reported CROX shares worth $5.9B at the end of Q2 2026, about 98% of the company. The largest holder is BlackRock, Inc. with 9.4%.
Funds and institutions (13F) 98%Everyone else 2%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 4.65M | 9.36% | $561M | -3% |
| FMR LLC (Fidelity) | 3.51M | 7.06% | $423M | -7% |
| Vanguard Capital Management LLC | 2.17M | 4.36% | $261M | -1% |
| Vanguard Portfolio Management LLC | 2.09M | 4.21% | $253M | +0% |
| Lsv Asset Management | 1.81M | 3.64% | $218M | +12% |
| State Street Corp | 1.59M | 3.20% | $192M | -1% |
| American Century Companies Inc | 1.47M | 2.97% | $178M | +71% |
| Fuller & Thaler Asset Management, Inc. | 1.30M | 2.61% | $157M | +4% |
| Dimensional Fund Advisors LP | 1.18M | 2.38% | $143M | -17% |
| Citadel Advisors LLC | 1.10M | 2.21% | $133M | +104% |
| Franklin Resources Inc | 1.04M | 2.08% | $125M | +120% |
| Geode Capital Management, LLC | 999,283 | 2.01% | $121M | -6% |
| Point72 Asset Management, L.P. | 892,537 | 1.80% | $108M | +50% |
| Morgan Stanley | 889,601 | 1.79% | $107M | +42% |
| Himalaya Capital Management LLC | 887,093 | 1.79% | $107M | No change |
| WIT Partners Advisory Pte. Ltd. | 875,000 | 1.76% | $106M | -69% |
| D. E. Shaw & Co., Inc. | 869,507 | 1.75% | $105M | +112% |
| No Street GP LP | 820,000 | 1.65% | $98.9M | -6% |
| Patient Capital Management, LLC | 799,426 | 1.61% | $96.4M | -5% |
| Norges Bank | 782,672 | 1.58% | $94.4M | – |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, CROX insiders reported $613K of open-market purchases and $23M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Douglas J Treff | Director | Sale | 10,714 | $159.21 | $1.7M | Form 4 |
| Nov 3, 2026 | Andrew Rees | CEO | Sale | 18,049 | $152.25 | $2.7M | Form 4 |
| Nov 3, 2026 | Andrew Rees | CEO | Sale | 17,251 | $153.28 | $2.6M | Form 4 |
| Nov 3, 2026 | Andrew Rees | CEO | Sale | 4,700 | $153.94 | $724K | Form 4 |
| Nov 2, 2026 | Douglas J Treff | Director | Sale | 3,416 | $150.70 | $515K | Form 4 |
| Nov 2, 2026 | Douglas J Treff | Director | Sale | 3,101 | $151.81 | $471K | Form 4 |
| Nov 2, 2026 | Douglas J Treff | Director | Sale | 7,185 | $152.85 | $1.1M | Form 4 |
| Nov 2, 2026 | Douglas J Treff | Director | Sale | 1,100 | $153.70 | $169K | Form 4 |
| Oct 30, 2026 | Rupert George Campbell | Vice president | Sale | 2,645 | $150.87 | $399K | Form 4 |
| Oct 30, 2026 | Ronald Frasch | Director | Sale | 15,000 | $153.51 | $2.3M | Form 4 |
| Sep 15, 2026 | Thomas J Smach | Director | Purchase | 680 | $111.49 | $75.8K | Form 4 |
| Sep 15, 2026 | Beth J Kaplan | Director | Purchase | 885 | $112.12 | $99.2K | Form 4 |
| Sep 10, 2026 | Thomas J Smach | Director | Purchase | 1,000 | $109.27 | $109K | Form 4 |
| Sep 10, 2026 | Thomas J Smach | Director | Purchase | 3,000 | $109.42 | $328K | Form 4 |
| Aug 10, 2026 | Andrew Rees | CEO | Sale | 9,576 | $138.38 | $1.3M | Form 4 |
| Aug 10, 2026 | Andrew Rees | CEO | Sale | 8,696 | $139.39 | $1.2M | Form 4 |
| Aug 10, 2026 | Andrew Rees | CEO | Sale | 800 | $140.02 | $112K | Form 4 |
| Aug 7, 2026 | Andrew Rees | CEO | Sale | 4,204 | $137.96 | $580K | Form 4 |
| Aug 7, 2026 | Andrew Rees | CEO | Sale | 928 | $139.04 | $129K | Form 4 |
| Aug 7, 2026 | Andrew Rees | CEO | Sale | 5,796 | $137.41 | $796K | Form 4 |
| Jun 5, 2026 | Andrew Rees | CEO | Sale | 6,900 | $116.97 | $807K | Form 4 |
| Jun 5, 2026 | Andrew Rees | CEO | Sale | 9,988 | $119.11 | $1.2M | Form 4 |
| Jun 5, 2026 | Andrew Rees | CEO | Sale | 15,800 | $117.94 | $1.9M | Form 4 |
| Feb 20, 2026 | Anne Mehlman | Vice president | Sale | 12,145 | $100.06 | $1.2M | Form 4 |
| Feb 20, 2026 | Thomas J Smach | Director | Sale | 4,963 | $100.00 | $496K | Form 4 |
| Feb 13, 2026 | Thomas J Smach | Director | Sale | 5,000 | $98.41 | $492K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Andrew Rees | Chief Executive Officer, Director | – | $14.1M | Nov 3, 2026 |
| Douglas J Treff | Director | – | $4M | Nov 4, 2026 |
| Ronald Frasch | Director | – | $2.3M | Oct 30, 2026 |
| Thomas J Smach | Director | $513K | $988K | Sep 15, 2026 |
| Anne Mehlman | EVP & Crocs Brand President | – | $1.2M | Feb 20, 2026 |
| Rupert George Campbell | EVP, Brand President, HEYDUDE | – | $399K | Oct 30, 2026 |
| Beth J Kaplan | Director | $99.2K | – | Sep 15, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
CROX short interest
Moderate short interest. 9.5% of CROX shares are sold short: about 1 share in 11. Over the last 12 reports the number of shares short went down 14%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 4.33M CROX shares were sold short, 9.5% of the shares outstanding, down 4.9% from the report before. At the average daily volume of 1.44M shares, buying them all back would take about 3.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 4.33M | 9.47% | -5% | 1.44M | 3.0 |
| Oct 15, 2026 | 4.55M | 9.49% | -9% | 1.04M | 4.4 |
| Sep 30, 2026 | 4.98M | 10.39% | +6% | 1.25M | 4.0 |
| Sep 15, 2026 | 4.68M | 9.76% | +2% | 977,703 | 4.8 |
| Aug 31, 2026 | 4.57M | 9.53% | +5% | 936,746 | 4.9 |
| Aug 14, 2026 | 4.35M | 9.08% | -1% | 901,954 | 4.8 |
| Jul 31, 2026 | 4.42M | 9.21% | -11% | 1.08M | 4.1 |
| Jul 15, 2026 | 4.94M | 9.95% | +4% | 1.03M | 4.8 |
| Jun 30, 2026 | 4.77M | 9.60% | -13% | 1.20M | 4.0 |
| Jun 15, 2026 | 5.46M | 10.99% | +0% | 1.23M | 4.4 |
| May 29, 2026 | 5.46M | 10.99% | +8% | 1.38M | 4.0 |
| May 15, 2026 | 5.05M | 10.17% | +27% | 1.06M | 4.8 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Crocs company events
Crocs filed 5 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Oct 29, 2026.
- Oct 29, 2026ResultsReleased financial results. Filing
- Jul 30, 2026AnnouncementThe Company also announced that its Board of Directors authorized the increase of the Company’s existing common stock repurchase authorization by $1.5 billion. Filing
- Jun 10, 2026LeadershipCrocs, Inc. held its 2026 annual meeting of stockholders as a virtual meeting online live via audio webcast, at which the Company’s stockholders approved the Company’s 2026 Equity Incentive Plan. Filing
- Apr 30, 2026ResultsReleased financial results. Filing
- Feb 12, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Crocs financials
Famous investors that hold CROX
9 of the 50 well-known investors we track reported holding CROX in their latest 13F filing. The largest position is Ken Griffin's, worth $137M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 1.17M | $137M | 0.1% | +6% |
| Li Lu · Himalaya Capital | Q3 2026 | 887,093 | $104M | 2.8% | No change |
| David Einhorn · Greenlight Capital (DME) | Q3 2026 | 653,800 | $76.7M | 2.2% | -2% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 540,981 | $63.5M | 0.1% | -39% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 190,440 | $22.3M | 0.1% | +18% |
| Israel Englander · Millennium Management | Q3 2026 | 80,542 | $9.4M | 0.0% | +9% |
| Bill Miller · Miller Value Partners | Q3 2026 | 28,856 | $3.4M | 0.7% | No change |
| Jeremy Grantham · GMO | Q3 2026 | 7,986 | $937K | 0.0% | -79% |
| Lee Ainslie · Maverick Capital | Q3 2026 | 2,183 | $256K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Crocs, Inc. (CROX) stock
Who owns the most CROX stock?
The largest reported owner of Crocs, Inc. (CROX) is BlackRock, Inc., with 9.4% of the company. In total, 497 funds and institutions reported holding CROX at the end of Q2 2026, together about 98% of the shares. See the largest owners.
Are CROX insiders buying or selling?
In the last 12 months, CROX insiders reported 4 open-market purchases worth $613K and 22 sales worth $23M. The latest trade was on Nov 4, 2026. See every trade.
What is the short interest in CROX?
As of Oct 30, 2026, 4.33M CROX shares were sold short, 9.5% of the shares outstanding, down 4.9% from the report before. At the average daily volume of 1.44M shares, buying them all back would take about 3.0 trading days (days to cover). See the history.
Which famous investors hold CROX?
9 of the 50 well-known investors we track reported CROX in their latest 13F filing, including Ken Griffin, Li Lu, David Einhorn. The largest position is worth $137M. See all holders.
Executive pay
Crocs's chief executive was paid a total of $11M for the year ended Dec 31, 2025, down 12% from $12.4M the year before. In the last 12 months, Crocs's executives and directors bought $613K of stock on the open market and sold $23M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.